Literature DB >> 19557500

Evaluation of neo-angiogenesis in a case of chordoid meningioma.

Valeria Barresi1,2, Giovanni Tuccari3.   

Abstract

Chordoid is a rare variant of meningioma that displays a high recurrence rate. In this study we evaluated the immunohistochemical expression of factors that regulate the neo-angiogenesis process in a case of chordoid meningioma with an adverse clinical course. A high microvessel density (MVD), as well as high VEGF and VEGF-R1 expression, was encountered in this tumor. By contrast, the anti-angiogenic factor semaphorin3A, highly expressed in this chordoid meningioma, was ineffective because of the absence of its receptor neuropilin-1. We suggest that VEGF expression and MVD may represent significant prognostic factors in chordoid meningiomas.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19557500     DOI: 10.1007/s11060-009-9942-0

Source DB:  PubMed          Journal:  J Neurooncol        ISSN: 0167-594X            Impact factor:   4.130


  11 in total

1.  "Malignancy" in meningiomas: a clinicopathologic study of 116 patients, with grading implications.

Authors:  A Perry; B W Scheithauer; S L Stafford; C M Lohse; P C Wollan
Journal:  Cancer       Date:  1999-05-01       Impact factor: 6.860

2.  Meningioma grading: an analysis of histologic parameters.

Authors:  A Perry; S L Stafford; B W Scheithauer; V J Suman; C M Lohse
Journal:  Am J Surg Pathol       Date:  1997-12       Impact factor: 6.394

3.  Chordoid meningioma: a clinicopathologic study of 42 cases.

Authors:  M E Couce; F V Aker; B W Scheithauer
Journal:  Am J Surg Pathol       Date:  2000-07       Impact factor: 6.394

4.  Absence of histological signs of tumor progression in recurrences of completely resected meningiomas.

Authors:  Davide Schiffer; Chiara Ghimenti; Valentina Fiano
Journal:  J Neurooncol       Date:  2005-06       Impact factor: 4.130

5.  Semaphorin3A immunohistochemical expression in human meningiomas: correlation with the microvessel density.

Authors:  Valeria Barresi; Enrica Vitarelli; Serenella Cerasoli
Journal:  Virchows Arch       Date:  2009-03-19       Impact factor: 4.064

6.  Collapsin: a protein in brain that induces the collapse and paralysis of neuronal growth cones.

Authors:  Y Luo; D Raible; J A Raper
Journal:  Cell       Date:  1993-10-22       Impact factor: 41.582

7.  Density of microvessels positive for CD105 (endoglin) is related to prognosis in meningiomas.

Authors:  Valeria Barresi; Serenella Cerasoli; Enrica Vitarelli; Giovanni Tuccari
Journal:  Acta Neuropathol       Date:  2007-06-27       Impact factor: 17.088

8.  The prognostic significance of MIB-1, p53, and DNA flow cytometry in completely resected primary meningiomas.

Authors:  A Perry; S L Stafford; B W Scheithauer; V J Suman; C M Lohse
Journal:  Cancer       Date:  1998-06-01       Impact factor: 6.860

9.  Semaphorin-3A and semaphorin-3F work together to repel endothelial cells and to inhibit their survival by induction of apoptosis.

Authors:  Noga Guttmann-Raviv; Niva Shraga-Heled; Asya Varshavsky; Cinthya Guimaraes-Sternberg; Ofra Kessler; Gera Neufeld
Journal:  J Biol Chem       Date:  2007-06-14       Impact factor: 5.157

10.  Chordoid meningioma: presentation of two case reports, review of the literature, and plea for data standardisation.

Authors:  P Kozler; V Benes; D Netuka; F Kramár; P Hrabal; F Charvát
Journal:  J Neurooncol       Date:  2008-03-05       Impact factor: 4.130

View more
  7 in total

1.  Chordoid meningioma: a clinicopathologic study of 11 cases at a single institution.

Authors:  Jui-Wei Lin; Jih-Tsun Ho; Yu-Jun Lin; You-Ting Wu
Journal:  J Neurooncol       Date:  2010-05-09       Impact factor: 4.130

2.  Angiogenesis as a predictor of recurrence in meningiomas.

Authors:  Valeria Barresi
Journal:  J Neurooncol       Date:  2010-05-26       Impact factor: 4.130

3.  Bevacizumab therapy for adults with recurrent/progressive meningioma: a retrospective series.

Authors:  Emil Lou; Ashley L Sumrall; Scott Turner; Katherine B Peters; Annick Desjardins; James J Vredenburgh; Roger E McLendon; James E Herndon; Frances McSherry; Julie Norfleet; Henry S Friedman; David A Reardon
Journal:  J Neurooncol       Date:  2012-04-26       Impact factor: 4.130

4.  Chordoid meningioma in a patient with lymphangioleiomyomatosis.

Authors:  Joaquin Campos-Franco; Esteban Otero; Elena Lopez-Garcia; Ihab Abdulkader; Arturo Gonzalez-Quintela
Journal:  J Neurooncol       Date:  2011-06-05       Impact factor: 4.130

5.  Chordoid meningioma: a retrospective series of seven consecutive cases.

Authors:  Emiliano Passacantilli; Gennaro Lapadula; Federico Caporlingua; Jacopo Lenzi; Manila Antonelli; Francesca Santoro; Antonio Santoro
Journal:  Neurol Sci       Date:  2013-04-18       Impact factor: 3.307

6.  Perfusion computed tomography of intracranial meningiomas: In vivo correlation of cerebral blood volume and vascular permeability.

Authors:  Francesca Granata; Rosa Morabito; Concetta Alafaci; Valeria Barresi; Francesco Tomasello; Sergio Vinci; Enricomaria Mormina; Alessandro Calamuneri; Giovanni Grasso; Francesco Maria Salpietro; Marcello Longo
Journal:  Neuroradiol J       Date:  2015-06

Review 7.  Role of bevacizumab for treatment-refractory meningiomas: A systematic analysis and literature review.

Authors:  Aaron J Franke; William Paul Skelton; Lindsey E Woody; Amade Bregy; Ashish H Shah; Kunal Vakharia; Ricardo J Komotar
Journal:  Surg Neurol Int       Date:  2018-07-13
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.